Trials / Terminated
TerminatedNCT00670111
Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will look at how pacing your heart may assist your daily activities and how you are feeling.
Detailed description
RESET is a multicenter trial that will assess the effect of pacing in heart failure patients with a normal ejection fraction (or diastolic heart failure). The purpose of the RESET study is to evaluate the effect of pacing on exercise capacity and quality of life in this heart failure population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Insignia Plus / Ultra (Guidant/Boston Scientific) | Cardiac pacing using any Guidant/Boston Scientific Implantable Pacemaker System with rate-modulation and any compatible intracardiac lead system. |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2008-05-01
- Last updated
- 2017-05-19
- Results posted
- 2017-05-19
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00670111. Inclusion in this directory is not an endorsement.